Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study.

× No keyword cloud information.

8 in total

1. A complex case of anti-GAD antibody-related syndrome treated with Rituximab.

Authors: D Baroncini; F Spagnolo; L Sarro; G Comi; M A Volonte'
Journal: Neurol Sci Date: 2013-02-13 Impact factor: 3.307

2. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.

Authors: Zoya Georgieva; Matthew Parton
Journal: BMJ Case Rep Date: 2014-01-13

Review 3. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.

Authors: Henrik Gensicke; David Leppert; Özgür Yaldizli; Raija L P Lindberg; Matthias Mehling; Ludwig Kappos; Jens Kuhle
Journal: CNS Drugs Date: 2012-01-01 Impact factor: 5.749

4. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.

Authors: Vincent Planche; Ana Marques; Miguel Ulla; Marc Ruivard; Franck Durif
Journal: Cerebellum Date: 2014-06 Impact factor: 3.847

5. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Authors: Marta Rizzi; Rolf Knoth; Christiane S Hampe; Peter Lorenz; Marie-Lise Gougeon; Brigitte Lemercier; Nils Venhoff; Francesca Ferrera; Ulrich Salzer; Hans-Jürgen Thiesen; Hans-Hartmut Peter; Ulrich A Walker; Hermann Eibel
Journal: PLoS One Date: 2010-05-26 Impact factor: 3.240

Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study.

1. A complex case of anti-GAD antibody-related syndrome treated with Rituximab.

2. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.

Review 3. Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.

4. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.

5. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Review 6. Evaluation of Treatment Outcomes in Patients with Stiff Person Syndrome with Rituximab vs. Standard of Care.

Review 7. Pragmatic Treatment of Stiff Person Spectrum Disorders.

8. Childhood stiff-person syndrome improved with rituximab.